These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 27542881)

  • 1. Residual Daytime Sleepiness in Obstructive Sleep Apnea After Continuous Positive Airway Pressure Optimization: Causes and Management.
    Chapman JL; Serinel Y; Marshall NS; Grunstein RR
    Sleep Med Clin; 2016 Sep; 11(3):353-63. PubMed ID: 27542881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Wakefulness-Promoting Agents on Sleepiness in Patients with Sleep Apnea Treated with CPAP: A Meta-Analysis.
    Sukhal S; Khalid M; Tulaimat A
    J Clin Sleep Med; 2015 Oct; 11(10):1179-86. PubMed ID: 25979103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of adjunctive modafinil treatment on residual excessive daytime sleepiness among nasal continuous positive airway pressure-treated japanese patients with obstructive sleep apnea syndrome: a double-blind placebo-controlled study.
    Inoue Y; Takasaki Y; Yamashiro Y
    J Clin Sleep Med; 2013 Aug; 9(8):751-7. PubMed ID: 23946704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On treatment but still sleepy: cause and management of residual sleepiness in obstructive sleep apnea.
    Launois SH; Tamisier R; Lévy P; Pépin JL
    Curr Opin Pulm Med; 2013 Nov; 19(6):601-8. PubMed ID: 24060983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Findings of the Maintenance of Wakefulness Test and its relationship with response to modafinil therapy for residual excessive daytime sleepiness in obstructive sleep apnea patients adequately treated with nasal continuous positive airway pressure.
    Inoue Y; Miki M; Tabata T
    Sleep Med; 2016; 27-28():45-48. PubMed ID: 27938918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal treatment of obstructive sleep apnea and excessive sleepiness.
    Rosenberg R; Doghramji P
    Adv Ther; 2009 Mar; 26(3):295-312. PubMed ID: 19337706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modafinil for treatment of residual excessive sleepiness in nasal continuous positive airway pressure-treated obstructive sleep apnea/hypopnea syndrome.
    Black JE; Hirshkowitz M
    Sleep; 2005 Apr; 28(4):464-71. PubMed ID: 16171291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of armodafinil on cortical activity and working memory in patients with residual excessive sleepiness associated with CPAP-Treated OSA: a multicenter fMRI study.
    Greve DN; Duntley SP; Larson-Prior L; Krystal AD; Diaz MT; Drummond SP; Thein SG; Kushida CA; Yang R; Thomas RJ
    J Clin Sleep Med; 2014 Feb; 10(2):143-53. PubMed ID: 24532997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management.
    Rosenberg R; Schweitzer PK; Steier J; Pepin JL
    Postgrad Med; 2021 Sep; 133(7):772-783. PubMed ID: 34292843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modafinil improves daytime sleepiness in patients with mild to moderate obstructive sleep apnoea not using standard treatments: a randomised placebo-controlled crossover trial.
    Chapman JL; Kempler L; Chang CL; Williams SC; Sivam S; Wong KK; Yee BJ; Grunstein RR; Marshall NS
    Thorax; 2014 Mar; 69(3):274-9. PubMed ID: 24287166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of armodafinil on simulated driving and self-report measures in obstructive sleep apnea patients prior to treatment with continuous positive airway pressure.
    Kay GG; Feldman N
    J Clin Sleep Med; 2013 May; 9(5):445-54. PubMed ID: 23674935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cholinergic system may play a role in the pathophysiology of residual excessive sleepiness in patients with obstructive sleep apnea.
    Otuyama LJ; Rizzi CF; Piovezan RD; Werli KS; Brasil EL; Sukys-Claudino L; Tufik S; Poyares D
    Med Hypotheses; 2013 Sep; 81(3):509-11. PubMed ID: 23891038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Residual excessive daytime sleepiness in CPAP-treated obstructive sleep apnea].
    Buffle C; Gex G; Cervena K ; Younossian AB; Adler D
    Rev Med Suisse; 2014 Nov; 10(451):2214-8. PubMed ID: 25603569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Modafinil and Armodafinil in Patients With Obstructive Sleep Apnea: A Meta-analysis of Randomized Controlled Trials.
    Kuan YC; Wu D; Huang KW; Chi NF; Hu CJ; Chung CC; Tam KW; Huang YH
    Clin Ther; 2016 Apr; 38(4):874-88. PubMed ID: 26923035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on Persistent Excessive Daytime Sleepiness in OSA.
    Javaheri S; Javaheri S
    Chest; 2020 Aug; 158(2):776-786. PubMed ID: 32147246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alertness and psychomotor performance effects of the histamine-3 inverse agonist MK-0249 in obstructive sleep apnea patients on continuous positive airway pressure therapy with excessive daytime sleepiness: a randomized adaptive crossover study.
    Herring WJ; Liu K; Hutzelmann J; Snavely D; Snyder E; Ceesay P; Lines C; Michelson D; Roth T
    Sleep Med; 2013 Oct; 14(10):955-63. PubMed ID: 23920422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled study of armodafinil for excessive sleepiness in patients with treated obstructive sleep apnea and comorbid depression.
    Krystal AD; Harsh JR; Yang R; Rippon GA; Lankford DA
    J Clin Psychiatry; 2010 Jan; 71(1):32-40. PubMed ID: 20051221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic approaches for the management of symptoms and cardiovascular consequences of obstructive sleep apnea in adults.
    Dopp JM; Morgan BJ
    Sleep Breath; 2010 Dec; 14(4):307-15. PubMed ID: 20582741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sleepiness, continuous positive airway pressure and the obstructive sleep apnea hypopnea syndrome].
    Lerousseau L
    Rev Mal Respir; 2018 Feb; 35(2):116-133. PubMed ID: 29454715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery Mimicking "Ideal" CPAP Adherence Does Not Improve Wakefulness or Cognition in Chronic Murine Models of OSA: Effect of Wake-Promoting Agents.
    Badran M; Puech C; Barrow MB; Runion AR; Gozal D
    Arch Bronconeumol; 2023 Dec; 59(12):805-812. PubMed ID: 37783638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.